Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

11.36
+0.08000.71%
Volume:401.41K
Turnover:4.48M
Market Cap:219.72M
PE:-1.87
High:11.55
Open:11.27
Low:10.62
Close:11.28
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:0.90
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:2.15
PE(LYR):-1.93

Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Mar 20

Corbus Pharmaceuticals Holdings Inc. Stock Sheds 6.0%, Underperforms Peers

Dow Jones
·
Mar 19

Corbus CEO Yuval Cohen to join BMO Metabolic Health Summit panel

Reuters
·
Mar 18

Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Mar 17

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Mar 14

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Mar 13

Corbus Pharmaceuticals files $300M mixed securities shelf

TIPRANKS
·
Mar 12

Corbus Pharmaceuticals Holdings Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing

THOMSON REUTERS
·
Mar 12

Corbus Pharmaceuticals Holdings Inc. Stock Climbs 3.9%, Outperforms Peers

Dow Jones
·
Mar 12

Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.1%, Outperforms Market

Dow Jones
·
Mar 11

Corbus Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Mar 10

Corbus Pharmaceuticals Holdings : Oppenheimer Raises Target Price to $57 From $53

THOMSON REUTERS
·
Mar 10

Corbus Pharmaceuticals price target raised to $57 from $53 at Oppenheimer

TIPRANKS
·
Mar 10

Corbus Pharmaceuticals Holdings Inc. Stock Rallies 19.2%, Outperforms Peers

Dow Jones
·
Mar 10

Corbus Pharmaceuticals reports Q4 EPS ($1.25), consensus ($1.58)

TIPRANKS
·
Mar 09

Corbus Pharmaceuticals Q4 EPS $(1.25) Beats $(1.38) Estimate

Benzinga Earnings
·
Mar 09

Corbus Pharmaceuticals Q4 net loss rises 116% to USD 20.56 million

Reuters
·
Mar 09

Corbus Pharmaceuticals Q4 Basic EPS USD -1.25

THOMSON REUTERS
·
Mar 09

Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update

GlobeNewswire
·
Mar 09

Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.58 a share - Earnings Preview

Reuters
·
Mar 06